All In Biotech

Drug Trial Radar · NCT05004675

Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients

Randomized Open Label, Phase 3 Study to Compare the Efficacy and Safety of Lerodalcibep (LIB003) to Inclisiran in Patients at Very High or High Risk for CVD, on Stable Lipid-Lowering Therapy Requiring Additional LDL-C Reduction

Last checked: Nov 20, 2026Latest source record: Oct 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 166 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

166

Actual

Start

Jun 20, 2022

Primary completion

May 30, 2024

Study completion Oct 15, 2024

Sponsor

Lead sponsor
LIB Therapeutics LLCIndustry
Sponsor type
Industry
Collaborators
Medpace, Inc.
First posted
Aug 13, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Comparison of LDL-C reductions of lerodalcibep (LIB003) 300 mg to inclisiran (Leqvio®) 284 in patients at very-high risk or high-risk for CVD on stable diet and oral LDL-C-lowering drug therapy

Conditions

  • Hypercholesterolemia
  • Atherosclerotic Ischemic Disease

Interventions

  • lerodalcibepBiological

    300 mg

  • InclisiranDrug

    284 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. LDL-C changeTime frame: Day 270

Locations

7 sites in 5 countries. Site status is shown where the registry gives one.

  • CHU de Nantes - Hôpital Nord Laennec

    Nantes, Cedex 01, France

  • Hopitaux de Marseille

    Marseille, Cedex 05, France

  • Universitätsklinikum Heidelberg - Medizinische Klinik

    Heidelberg, Germany

  • The Lipid Clinic (Oslo University Hospital)

    Oslo, Nydalen, Norway

  • Hospital Universitario Miguel Servet

    Zaragoza, Spain

  • Oak Tree Surgery and Pensilva Health Centre

    Liskeard, Cornwall, United Kingdom

  • Ashton Medical Group

    Ashton-under-Lyne, Lancashire, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.